Adamera Minerals (ADZ) Stock Price, News & Analysis

Company Overview

Adamera Minerals Corp., an exploration stage company, acquires and explores for precious metals. The company primarily explores for silver, gold, copper, and zinc deposits. Its principal properties are the Cooke Mountain, Empire Creek, Buckhorn 2.0, Talisman, and Flaghill located in Washington State, the United States. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.24 to C$0.25
• 50-Day Range: C$0.14 to C$0.25
• 52-Week Range: C$0.10 to C$0.80
• Volume: 12,502 shs
• Average Volume: 22,229 shs
• Market Capitalization: C$6.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ADZ Stock Analysis - Frequently Asked Questions

How have ADZ shares performed this year?

Adamera Minerals' stock was trading at C$0.05 at the beginning of the year. Since then, ADZ stock has increased by 444.4% and is now trading at C$0.25.
View the best growth stocks for 2024 here.

How were Adamera Minerals' earnings last quarter?

Adamera Minerals Corp. (CVE:ADZ) announced its quarterly earnings data on Thursday, August, 15th. The company reported ($0.01) earnings per share for the quarter.

How do I buy shares of Adamera Minerals?

Shares of ADZ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Adamera Minerals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Adamera Minerals investors own include Aadi Bioscience (AADI), Anavex Life Sciences (AVXL), Biopharmx (BPMX), Can-Fite BioPharma (CANF), CorMedix (CRMD), Galmed Pharmaceuticals (GLMD) and Melinta Therapeutics (MLNT).

Company Calendar

• Last Earnings: 8/15/2024
• Today: 11/05/2024
• Next Earnings (Estimated): 11/22/2024

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Other Precious Metals & Mining
• Sub-Industry: N/A
• Current Symbol: CVE:ADZ
• CUSIP: N/A
• CIK: N/A
• Web: www.adamera.com
• Phone: 604-689-2010
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-1,470,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -18.79%
• Return on Assets: -10.50%

Debt

• Debt-to-Equity Ratio: 4.67
• Current Ratio: 0.64
• Quick Ratio: 3.54

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.02 per share
• Price / Cash Flow: 10.00
• Book Value: C$0.31 per share
• Price / Book: 0.79

Miscellaneous

• Outstanding Shares: 27,220,000
• Free Float: N/A
• Market Cap: C$6.67 million
• Optionable: Not Optionable
• Beta: 1.15